Hints and tips:
...I think a lot of people were anticipating a V-shaped recovery . . . People are now waking up the realisation that volatility is going to be normal going forward.”...
...2.5 per cent....
...And its Sharpe ratio — a measure of return adjusting for risk — has also improved from 2.65 in the earlier period to 2.78 over the past 10 years....
...Is it better, worse or different from the Boris Johnson and previous Tory administration?...
...UK prime minister Boris Johnson said this week that it was “touch and go” whether COP26 would be a success....
...and Johnson & Johnson shots....
...“So the majority writes its own set of rules, limiting Section 2.”...
...Prime minister Boris Johnson said there were “serious issues” surrounding racism within the UK that needed to be addressed....
...The dollar index, which charts the progress of the greenback against major currencies, rose 0.2 per cent....
...The rare blood-clotting reaction that has disrupted the rollout of the Oxford/AstraZeneca and Johnson & Johnson coronavirus vaccines is now the focus of a heated scientific debate over why the shots may...
...While based in Fort Devens, Massachusetts, he met Alma Johnson of Birmingham, Alabama, then an audiologist in Boston....
...The US, alongside Japan, Australia and India, launched a plan this month to deliver 1bn doses of Johnson & Johnson’s Covid-19 vaccine to south-east Asian nations....
...It said it had bought Biofreeze following the acquisition last month of female sexual wellness brand Queen V....
...Smart reads Cavalier credit Star investor-turned inmate Daniel Kamensky wasn’t the first to take advantage of chaotic credit markets when he tried to finagle a sweetheart deal for his hedge fund....
...Friday’s trading was more muted, with an overall gain of 0.2 per cent....
...Catalent has partnered with AstraZeneca to manufacture its vaccine in Anagni, Italy, and is currently planning a large expansion of its production lines to churn out Johnson & Johnson’s shot in Europe....
...Several other Covid-19 vaccines in development, including the Russian Sputnik-V and candidates from Johnson & Johnson of the US and CanSino of China, use adenoviruses....
...As the FT’s Andrew Edgecliffe-Johnson and Taylor Nicole Rogers investigated, the numbers are less evocative of the activist rhetoric expressed over the summer....
...Global Covid-19 deaths globally rose above 2.5m on Thursday, according to Johns Hopkins University....
...UK ministers and media branded Monday “V-Day” as the first doses of the Pfizer/BioNTech vaccine were administered....
...on Thursday after the ride-hailing company promised profitability in the final quarter of this year, officials in London and Washington told the FT that Donald Trump vented in “apoplectic” fury at Boris Johnson...
...And while companies from Argentina — seemingly heading for a sovereign default — account for 2 per cent of the index, other struggling countries such as Lebanon and Ecuador are virtually absent, limiting...
...At the end of January, Novavax, a US vaccine company, and Johnson & Johnson, whose one-shot vaccine is ideal for developing countries, both posted promising phase 3 data....
...2 per cent inflation”....
...Next year, “analysts are projecting earnings growth of 28.2 per cent and revenue growth of 8.5 per cent” according to FactSet....
International Edition